Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

25
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
25
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

367
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
367
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

204
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
204
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

374
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
374
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

277
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
277
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

393
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
393

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EVALUATING MULTIPLEX DIAGNOSTIC TEST USING PARTIALLY ORDERED BAYES CLASSIFIER.

The annals of applied statistics·2026
Same author

Evaluating movement breaks as a public health strategy to mitigate the harms of prolonged sitting: a large-scale pragmatic intervention.

British journal of sports medicine·2026
Same author

Digital personalized trials of a multicomponent behavioral change intervention for increasing habitual low-intensity physical activity in middle-aged and older healthcare workers: results of a feasibility study.

Pilot and feasibility studies·2026
Same author

GENERALIZATION ERROR BOUNDS OF DYNAMIC TREATMENT REGIMES IN PENALIZED REGRESSION-BASED LEARNING.

Annals of statistics·2026
Same author

A SEQUENTIAL SIGNIFICANCE TEST FOR TREATMENT BY COVARIATE INTERACTIONS.

Statistica Sinica·2026
Same author

Comparing Adaptive Interventions under a General Sequential Multiple Assignment Randomized Trial Design via Multiple Comparisons with the Best.

Journal of statistical planning and inference·2026

Related Experiment Video

Updated: Feb 22, 2026

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.2K

Stochastic Approximation and Modern Model-based Designs for Dose-Finding Clinical Trials.

Ying Kuen Cheung1

  • 1Department of Biostatistics, Columbia University, New York, New York, USA 10032.

Statistical Science : a Review Journal of the Institute of Mathematical Statistics
|January 4, 2011
PubMed
Summary

Stochastic approximation, a method from engineering, can improve dose-finding clinical trials. This review explores its relevance to statistical methodology for estimating optimal drug doses from response data.

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.6K

Related Experiment Videos

Last Updated: Feb 22, 2026

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.2K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.6K

Area of Science:

  • Statistics
  • Biostatistics
  • Clinical Trials

Background:

  • Stochastic approximation, introduced by Robbins and Monro in 1951, is applicable to estimating quantal response data.
  • Dose-finding study methodology has significantly advanced since the 1990s, focusing on percentile estimation.
  • The dose-finding literature has largely developed independently of stochastic approximation literature.

Purpose of the Study:

  • To explore the connections and discrepancies between dose-finding and stochastic approximation methodologies.
  • To highlight the potential and future applications of stochastic approximation in dose-finding clinical trials.
  • To guide dose-finding methodology towards more rigorous approaches for complex clinical scenarios.

Main Methods:

  • Literature review comparing dose-finding and stochastic approximation.
  • Analysis of the historical development and independent evolution of both fields.
  • Examination of the applicability of stochastic approximation to clinical trial data.

Main Results:

  • Despite conceptual similarities, dose-finding and stochastic approximation have evolved separately.
  • Stochastic approximation is underutilized in clinical studies compared to other fields.
  • There is significant potential for stochastic approximation to enhance dose-finding trial design and analysis.

Conclusions:

  • Reintegrating stochastic approximation principles can strengthen dose-finding methodology.
  • This integration will enable more robust statistical approaches for complex clinical trial designs.
  • Future research should focus on bridging the gap between these two statistical fields for improved clinical outcomes.